Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Resmed Inc. buy Robert W. Baird

Start price
€223.10
24.09.24 / 50%
Target price
€251.24
24.09.25
Performance (%)
-2.73%
Price
€217.00
26.09.24
Summary
This prediction is currently active. With a performance of -2.73%, the BUY prediction for Resmed Inc. by Robert_W__Baird is down slightly. This prediction currently runs until 24.09.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w
Resmed Inc. -2.73%
iShares Core DAX® 1.518%
iShares Nasdaq 100 1.240%
iShares Nikkei 225® 2.808%
iShares S&P 500 0.403%

Comments by Robert_W__Baird for this prediction

In the thread Resmed Inc. diskutieren
Prediction Buy
Perf. (%) -2.73%
Target price 251.244
Change
Ends at 24.09.25

ResMed Inc. (NYSE: RMD) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $280.00 price target on the stock.
Ratings data for RMD provided by MarketBeat